1. A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients. Issue 2 (November 2016) Authors: Joseph, Nuradh; Taylor, Cathy; O'Hara, Catherine; Choudhury, Ananya; Elliott, Tony; Logue, John; Wylie, James Journal: Radiotherapy and oncology Issue: Volume 121:Issue 2(2016:Nov.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 8 (August 2016) Authors: Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity. (20th June 2012) Authors: Thomson, David; Merrick, Sophie; Swindell, Ric; Coote, Joanna; Kelly, Kay; Stratford, Julie; Wylie, James; Cowan, Richard; Elliott, Tony; Logue, John; Choudhury, Ananya; Livsey, Jacqueline Other Names: Ben-Yosef Rami Academic Editor. Journal: Prostate cancer Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 16 (December 2015) Authors: Wilkins, Anna; Mossop, Helen; Syndikus, Isabel; Khoo, Vincent; Bloomfield, David; Parker, Chris; Logue, John; Scrase, Christopher; Patterson, Helen; Birtle, Alison; Staffurth, John; Malik, Zafar; Panades, Miguel; Eswar, Chinnamani; Graham, John; Russell, Martin; Kirkbride, Peter; O'Sullivan, Joe ... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Issue 22 (1st August 2022) Authors: Joffe, Johnathan K.; Cafferty, Fay H.; Murphy, Laura; Rustin, Gordon J.S.; Sohaib, Syed A.; Gabe, Rhian; Stenning, Sally P.; James, Elizabeth; Noor, Dipa; Wade, Simona; Schiavone, Francesca; Swift, Sarah; Dunwoodie, Elaine; Hall, Marcia; Sharma, Anand; Braybrooke, Jeremy; Shamash, Jonathan; Logue... Journal: Journal of clinical oncology Issue: Volume 40:Issue 22(2022) Page Start: 2468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcome and patient-reported toxicity in localised prostate cancer treated with dose-escalated hypofractionated intensity-modulated radiotherapy. Issue 4 (23rd April 2013) Authors: Thomson, David; Merrick, Sophie; Swindell, Ric; Wylie, James; Cowan, Richard; Elliott, Tony; Logue, John; Livsey, Jacqueline; Choudhury, Ananya Journal: Journal of radiotherapy in practice Issue: Volume 12:Issue 4(2013) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SABRE 1 (Surgery Against Brachytherapy – a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low–intermediate risk clinically localised prostate cancer. (4th July 2013) Authors: Eccles, Bryony K.; Cross, William; Rosario, Derek J.; Doble, Andrew; Parker, Chris; Logue, John; Little, Louisa; Stanton, Louise; Bottomley, David Journal: BJU international Issue: Volume 112:Number 3(2013:Aug.) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Issue 10260 (31st October 2020) Authors: Parker, Christopher C; Clarke, Noel W; Cook, Adrian D; Kynaston, Howard G; Petersen, Peter Meidahl; Catton, Charles; Cross, William; Logue, John; Parulekar, Wendy; Payne, Heather; Persad, Rajendra; Pickering, Holly; Saad, Fred; Anderson, Juliette; Bahl, Amit; Bottomley, David; Brasso, Klaus; Chah... Journal: Lancet Issue: Volume 396:Issue 10260(2020) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗